Pharma Marketing Network

MAY 6, 2023

While AI can be a powerful tool for creating effective marketing campaigns, it also poses significant ethical challenges. One of the main ethical concerns with using AI in pharmaceutical marketing is the potential for the technology to perpetuate biases and discrimination. “The ethics of artificial intelligence.”

Ethics 52

Ethics Marketing Pharmaceutical Training 52

European Pharmaceutical Review

MARCH 12, 2024

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance.

Government 90

Government Pharma Ethics Training 90

Pharma Marketing Network

DECEMBER 17, 2021

Companies are invited to reapply each year to be evaluated based on how their policies, actions, and results are impacting the environment, ethics, labor and human rights, and sustainable procurement. And last, but certainly not least—governance. Ethics is a skill.” Why make it inviting? What’s Next? Track, measure, and improve.

Pharma 103

Pharma Ethics Recruitment Government 103

Pharma Marketing Network

JULY 26, 2023

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. appeared first on Pharma Marketing Network.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

PM360

MARCH 22, 2024

Their impact extends beyond increasing participant numbers, encompassing broader contributions to research design, ethics, and addressing logistical barriers 2. Crucially, improved accessibility to collaborative research and advocacy networks is vital. Another major hurdle for the PAGs is funding. References: 1. Ther Adv Rare Dis.

Patients 52

Patients Recruitment Ethics Government 52

Nixon Gwilt Law

FEBRUARY 23, 2024

Nixon Gwilt Law (NGL) is excited to announce a significant expansion of our core capabilities through the addition of four attorneys with expertise in healthcare mergers and acquisitions , fundraising and venture capital , and corporate/business counsel. William added, “NGL is leading the way in serving healthcare innovators.

Specialization 52

Specialization Healthcare Healthcare Consulting 52

Nixon Gwilt Law

DECEMBER 16, 2021

What can Healthcare and Life Sciences businesses and investors anticipate for the healthcare industry in 2022? We asked our team five direct questions about innovations in healthcare, life sciences, and digital health in the coming year: What healthcare trends or opportunities are you most excited about?

Healthcare 52

Healthcare Healthcare Food and Drug Administration Ethics 52